Daniel Kalbacher

Check out this new #CJC #Editorial which: highlights the challenges of the TMVR screening process & provides a Glimpse into the Future Technological Needs and Requirements 👉 onlinecjc.ca/article/S0828-…

A cautionary tale about the transient dysfunction of a leadless pacemaker system after cardioversion - Be ready to pace! Just published online in Heart Rhythm Case Reports @JNikorowitsch heartrhythmcasereports.com/article/S2214-…

#LateBreakingClinicalTrials: In seinem Vortrag bei der #DGKJahrestagung präsentiert Prof. B. Köll das PRIME-MR Register.

🗞️ The EXPAND study is now out on #EJHF @ESC_Journals In our Editorial: 🎯#MitraClip NTR vs. XTR 🎯1y results w/ MitraClip 3rd gen 🎯how to reduce leaflet injury & SLDA 🌐Editorial: onlinelibrary.wiley.com/doi/10.1002/ej… 🌐Article: onlinelibrary.wiley.com/doi/full/10.10… @azeemlatib #CardioED #MedEd #TEER

#PRIMEMR @BenediktKoell @SebLudwig1 @AndreaScotti21 @AugustinCoisne @DanielKalbacher

@Obisht If low or normal height above the valve, start medial, than lateral. If height is rather high, focus on pathology: in DMR try to implant 1st device next to Main pathology, e.g. grap flail or prolapse with 2nd device.

Question to TEER Operators out there: if you have a large Jet which likely to require 2 Clips or more, what is your best strategy to tackle it ? Where do you start?

Transcatheter tricuspid valve replacement is emerging as a therapeutic option amongst patients with secondary tricuspid regurgitation. This systematic review and meta-analysis provides an overview of the early and late outcomes after isolated surgical TVR. ow.ly/c1jN50L1I5O

Cath lab personal before starting elective PCI receiving results of the REVIVED-BCIS2 trial

Want to know the outcomes of MitraClip in secondary MR since FDA approval? Come join me at #ESC2022 where I will be presenting the COAPT Post Approval Study as a Late-Breaker on Aug 28 @PaulMahoneyMD @PradeepYadavMD @_WayneBatchelor @JasonHRogersMD @colinbarkerMD @ESC_Journals

Atrial FMR is a frequent cause of FMR and can be effectively treated with TEER to improve symptoms at follow-up. Transcatheter Mitral Valve Repair in Patients With Atrial Functional Mitral Regurgitation pubmed.ncbi.nlm.nih.gov/35842361/

M-TEER for atrial functional #mitralvalve regurgitation (FMR)? Atrial FMR is a frequent cause of FMR & can be effectively treated w/ #MTEER. Check out the new results from EuroSMR registry: bit.ly/3oI9Us3 #JACCIMG #cvImaging #MitraClip #CardioTwitter #echofirst #vhdMR

Lucky Friday 🍀

ICYMI: A new staging classification of primary #vhdMR based on extra-mitral valve cardiac involvement, including severe LA dilatation & RV dysfunction, showed independent prognostic value. bit.ly/3x8gzPW #JACCIMG #EchoFirst #cvImaging

👍🏻👍🏻@NEJM #mybodymychoice

A patient with diabetes and recent NSTEMI treated with stent, clopidogrel, and atorvastatin ~2 months ago is transferred from OSH with ALT 1500, bilirubin 15 The leading diagnosis is statin liver injury But that's not what it is. Not at all 🧵 #livertwitter #liverstory

Failed vascular closure device after large-bore femoral access

Mean gradient outcomes post Mitral-TEER remain uncertain. See recent studies/Editorial: bit.ly/Koell_TEERMPG bit.ly/Yoon_TEERMPG bit.ly/MnGrad_Editori… @JACCJournals @ACCinTouch @escardio @BenediktKoell @DanielKalbacher @jeroenjbax1 @JHausleiter

Proud to share our latest analysis on the impact of elevated transmitral pressure gradient following M-TEER. Just published in JACC: Int #JACCJournals ➡️ authors.elsevier.com/a/1f01q6uPJvj6… Elevated gradient predicts outcomes in DMR, but not in FMR! @SebLudwig1 @DanielKalbacher

AHEAD OF PRINT: The results of this study emphasise the strengths and limitations of transcatheter mitral valve implantation (#TMVI) as a novel and promising therapy providing predictable elimination of mitral regurgitation in most patients. #EAPCI ow.ly/t3iI50HpME5

Impact of Mitral Valve Repair Technologies on Predictability of Post-Delivery Residual Mitral Regurgitation @DGK_org @escardio @AGIKinterv @JACCJournals @AHAMeetings